CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 61 filers reported holding CARDIFF ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,524 | -5.4% | 139,945 | 0.0% | 0.00% | – |
| Q2 2023 | $205,719 | -10.9% | 139,945 | 0.0% | 0.00% | – |
| Q1 2023 | $230,909 | -41.1% | 139,945 | -50.0% | 0.00% | – |
| Q4 2022 | $391,846 | +81.4% | 279,890 | +100.0% | 0.00% | – |
| Q3 2022 | $216,000 | -29.9% | 139,945 | 0.0% | 0.00% | – |
| Q2 2022 | $308,000 | -82.4% | 139,945 | -80.1% | 0.00% | – |
| Q1 2022 | $1,747,000 | -58.1% | 704,237 | +1.6% | 0.00% | – |
| Q4 2021 | $4,168,000 | -0.9% | 693,445 | +9.8% | 0.00% | – |
| Q3 2021 | $4,206,000 | +27.9% | 631,556 | +27.7% | 0.00% | – |
| Q2 2021 | $3,288,000 | +3155.4% | 494,491 | +4413.4% | 0.00% | – |
| Q1 2021 | $101,000 | -99.8% | 10,956 | -99.6% | 0.00% | -100.0% |
| Q4 2020 | $45,852,000 | – | 2,548,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |